Similar to YTX, in 2012 the patent “Use of gymnodimine, analogs, and derivatives for the treatment and/or prevention of neurodegenerative diseases associated with tau and β-amyloid” was filed by Botana et al. [88]. This evidence concerns the gene MAPT and neurodegenerative disease.